ATE203677T1 - Legionellosis-impfstoffe und verfahren zur deren herstellung - Google Patents

Legionellosis-impfstoffe und verfahren zur deren herstellung

Info

Publication number
ATE203677T1
ATE203677T1 AT96112524T AT96112524T ATE203677T1 AT E203677 T1 ATE203677 T1 AT E203677T1 AT 96112524 T AT96112524 T AT 96112524T AT 96112524 T AT96112524 T AT 96112524T AT E203677 T1 ATE203677 T1 AT E203677T1
Authority
AT
Austria
Prior art keywords
vaccines
pathogen
legionellosis
production
hosts
Prior art date
Application number
AT96112524T
Other languages
English (en)
Inventor
Marcus A Horwitz
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE203677T1 publication Critical patent/ATE203677T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT96112524T 1988-08-16 1989-08-15 Legionellosis-impfstoffe und verfahren zur deren herstellung ATE203677T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07232664 US5108745B1 (en) 1988-08-16 1988-08-16 Tuberculosis and legionellosis vaccines and methods for their production

Publications (1)

Publication Number Publication Date
ATE203677T1 true ATE203677T1 (de) 2001-08-15

Family

ID=22874048

Family Applications (2)

Application Number Title Priority Date Filing Date
AT89910005T ATE159857T1 (de) 1988-08-16 1989-08-15 Legionellosis-impfstoffe und verfahren zur herstellung
AT96112524T ATE203677T1 (de) 1988-08-16 1989-08-15 Legionellosis-impfstoffe und verfahren zur deren herstellung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT89910005T ATE159857T1 (de) 1988-08-16 1989-08-15 Legionellosis-impfstoffe und verfahren zur herstellung

Country Status (7)

Country Link
US (1) US5108745B1 (de)
EP (2) EP0753310B1 (de)
JP (1) JP2841094B2 (de)
AT (2) ATE159857T1 (de)
CA (1) CA1337333C (de)
DE (2) DE68929318T2 (de)
WO (1) WO1990001944A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509151B1 (en) * 1993-09-02 2003-01-21 Cornell Research Foundation, Inc. DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
US7300660B2 (en) * 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6818223B2 (en) * 1993-11-23 2004-11-16 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
CN1103781C (zh) 1993-11-23 2003-03-26 加利福尼亚大学 丰富的细胞外产物和其生产与使用方法
WO1996037219A1 (en) * 1995-05-23 1996-11-28 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) * 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6072048A (en) 1997-03-10 2000-06-06 Cornell Research Foundation, Inc. DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof
US6177086B1 (en) 1997-05-06 2001-01-23 Cornell Research Foundation, Inc. DNA molecule conferring on Mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US7595383B1 (en) * 1999-05-04 2009-09-29 University Of Medicine And Dentistry Of New Jersey Secreted proteins of Mycobacterium tuberculosis and their use as vaccines and diagnostic reagents
WO2001024820A1 (en) * 1999-10-07 2001-04-12 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
AU2001241738A1 (en) * 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
GB0012258D0 (en) 2000-05-19 2000-07-12 Fujitsu Ltd Transmission rate changes in communications networks
ATE442866T1 (de) * 2000-06-20 2009-10-15 Corixa Corp Fusionsproteine aus mycobakterium tuberculosis
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
EP1523331B1 (de) * 2002-07-13 2013-02-27 Statens Serum Institut Therapeutisches vakzin gegen tuberkulosis
US20060142251A1 (en) * 2002-11-15 2006-06-29 Gunther Harth Anti-microbial agents derived from methionine sulfoximine analogues
US7901932B2 (en) * 2005-03-17 2011-03-08 Phigenics, Llc Methods and compositions for rapidly detecting and quantifying viable Legionella
EP1869469B1 (de) * 2005-03-17 2011-12-07 Phigenics, LLC Methode zum schnellen nachweisen und quantifizieren lebensfähiger legionellen
US20100015171A1 (en) * 2008-07-15 2010-01-21 Statens Serum Institute Vaccines comprising tb 10.4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514509A (en) * 1981-09-21 1985-04-30 Indiana University Foundation Method for the diagnosis of Legionnaires' disease
GB8301600D0 (en) * 1983-01-21 1983-02-23 Btp Cocker Chem Ltd Control of legionella pneumophila in water systems
FR2541304A1 (fr) * 1983-02-21 1984-08-24 Centre Nat Rech Scient Anticorps monoclonaux anti-legionella, procede d'obtention et application au diagnostic de pneumonies
US4722891A (en) * 1984-06-20 1988-02-02 Board Of Regents, The University Of Texas System Methods and compositions for detection of Legionnaires' disease

Also Published As

Publication number Publication date
JP2841094B2 (ja) 1998-12-24
EP0753310A1 (de) 1997-01-15
JPH04501107A (ja) 1992-02-27
EP0432203A4 (en) 1991-11-06
CA1337333C (en) 1995-10-17
EP0432203B1 (de) 1997-11-05
DE68929318T2 (de) 2002-05-08
ATE159857T1 (de) 1997-11-15
DE68928432D1 (de) 1997-12-11
WO1990001944A1 (en) 1990-03-08
US5108745B1 (en) 1998-06-30
US5108745A (en) 1992-04-28
DE68928432T2 (de) 1998-03-05
DE68929318D1 (de) 2001-09-06
EP0432203A1 (de) 1991-06-19
EP0753310B1 (de) 2001-08-01

Similar Documents

Publication Publication Date Title
ATE203677T1 (de) Legionellosis-impfstoffe und verfahren zur deren herstellung
ES2092306T3 (es) Adyuvante para vacunas.
ES500567A0 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
HUP9900061A1 (hu) Alumínium-foszfátra adszorbeált konjugált poliszacharid antigént tartalmazó vakcinakompozíciók
DE68924162T2 (de) Stressproteine und verwendungen dafür.
CA2231603A1 (en) Chicken interleukin-15 and uses thereof
ES520259A0 (es) Un procedimiento para preparar un complejo inmunogeno no covalentes de polisacarido-proteina, y obtenido a partir de capsulas bacterianas.
DE3806565A1 (de) Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
ES543026A0 (es) Un metodo para preparar una vacuna pra inducir inmunidad a la tosferina.
FI875015A0 (fi) Vaccin mot juverinflammation.
DE69030099D1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
ATE273022T1 (de) Verfahren zur verstärkung zellularer immunantworten
EP0023731A3 (de) Verfahren zur Herstellung polyvalenter Virus-Impfstoffe in einem Einzelzellsystem, solche polyvalenten Impfstoffe und ihre Verwendung
FR2646776B1 (fr) Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
DE3787121D1 (de) Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen.
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
ATE91131T1 (de) Verfahren zum extrahieren von membranantigenen mit immunogenen eigenschaften aus humanen neoplastischen zellen und so erhaltene produkte.
BE855776A (fr) Vaccin antiparasitaire par voie orale, son procede de preparation et sa methode d'application chez les mammiferes
ATE152916T1 (de) Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind
TH809EX (th) โปรโตโซลแอนติเจล (กรรมวิธี)
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
TH12789A (th) วิธีการทำให้เนื้อและผลิตภัณฑ์ของเนื้อมีความอ่อนนุ่ม
RO62730A2 (fr) Procede de preparation de vaccin vivant,attenue,de la rougeole
TH3933EX (th) วัคซีนที่มีขอบเขตของการออกฤทธิ์กว้างที่ใช้ต่อต้านโรคโกโนเรีย
RO79572A2 (ro) Procedeu de preparare a unui vaccin gripal

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties